We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parkinson's Disease Foundation calls on research professionals

Parkinson's Disease Foundation calls on research professionals

March 10, 2014
CenterWatch Staff

The Parkinson's Disease Foundation (PDF) invites research professionals within industry, academia and government to partner with its trained patient advocates to bring about better treatments for Parkinson's disease. This week, PDF welcomes new members to its national network, which now includes more than 230 research advocates whose insights are critical to speeding drug development.

In the past five years, more than 400 research professionals have engaged PDF research advocates in setting research priorities, designing clinical trials and increasing study enrollment.  These partnerships have led to, among other outcomes, 700 people enrolling in clinical studies.

This week, more than 30 people with Parkinson's disease and care partners are undergoing training to join the network.

"I urge my colleagues in the field of Parkinson's disease research to work with these unique individuals.  It is incredibly effective," said Claire Henchcliffe, M.D., D.Phil., faculty member for the program, director of the PDF Research Center at Weill Cornell Medical College and associate professor of neurology and neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medical College in New York. "In my experience, PDF research advocates can enhance our work by bringing an understanding of what it means to live with Parkinson's disease."

Linda M. Morgan, M.B.A., R.Ph., a PDF research advocate from Asheville, N.C., who also is a faculty member for the program, said, "The community increasingly is recognizing the importance of the patient's voice. We want research professionals to know that, thanks to PDF's training and support, we are ready to hit the ground running to improve trials and solve Parkinson's disease."

Upcoming Events

  • 09Dec

    The Age of eSource: Modernizing Clinical Trials

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Patient-phsyician-consultation

    Giving Patients Back Their Voice in Clinical Trials

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing